Workflow
wanhua(600309)
icon
Search documents
万华化学,四大装置停产检修!
DT新材料· 2025-05-22 15:28
(1) 福建工业园 根据化工企业生产工艺的要求,为确保生产装置安全有效运行,按照年度计划,本公司福建工业园 80 万吨/年 MDI 装置、36 万吨/年 TDI 装置、40 万 吨/年 PVC 装置及相关配套装置 将于 2025年6月5日 开始停产检修,预计检修 45 天 左右。 【DT新材料】 获悉,近日, 万华化学 公告,公司 福建工业园 80万吨/年MDI装置、36万吨/年TDI装置、40万吨/年PVC装置 以及 烟台产业园 100万 吨/年乙烯一期装置 将于 6月 开始停产检修。 说明: 本文部分素材来自于万华化学公司 官网及网络公开信息,由作者重新编写,转载请备注来源,本平台发布仅为了传达一种不同观点,不代表对该观点赞同或支 持。如果有任何问题,请联系我们:dtmaterial (微信)15355132586 (2) 万华化学烟台产业园 100 万吨/年乙烯一期装置为实现原料多元化,将于 2025年6月3日 开始停产进行技术改造,改造周期约 5个月 。在此期间,烟台产业园120万吨/年乙烯 二期装置正常生产,以尽量满足客户的需求。 主办单位 浙江省 生物基高分子材料重点实验室 宁波德泰中研信息科技有 ...
晚间公告丨5月22日这些公告有看头
第一财经· 2025-05-22 15:21
Group 1 - Hongchuang Holdings plans to acquire 100% equity of Shandong Hongtuo Industrial for 63.518 billion yuan, transforming from a single aluminum deep processing business to a full industry chain including electrolytic aluminum, alumina, and aluminum deep processing [3] - LIZHU Group intends to acquire 64.81% of Vietnam's Imexpharm Corporation for approximately 1.587 billion yuan, enhancing its presence in the pharmaceutical sector [4][5] - China Power Construction reported a new contract amount of 386.49 billion yuan from January to April, a year-on-year decrease of 4.9% [7] Group 2 - Wanhua Chemical announced a scheduled maintenance for its production facilities, including a five-month technical upgrade for its Yantai ethylene unit, which will not significantly impact operations [8] - Changhong High-Tech received a warning letter from the Ningbo Securities Regulatory Bureau for failing to disclose related party transactions in a timely manner [9] - Highgreat plans to invest 10 million yuan in Blue Core Computing, which focuses on RISC-V architecture chips [10] Group 3 - Xidi Micro plans to increase capital by 30 million USD in its wholly-owned subsidiary Hong Kong Xidi Micro to support its expanding business [12] - Bichuang Technology lost its high-tech enterprise qualification, resulting in an increase in corporate income tax rate from 15% to 25% for the years 2023 to 2025 [13] - Tonghua Dongbao intends to transfer 5.7% of its shares in Xiamen Tebao Biological Engineering for a total of 1.301 billion yuan [16] Group 4 - Tian Tie Technology signed a strategic cooperation agreement with Shenzhen Xinjie Energy to collaborate on solid-state battery lithium metal anode materials [23] - Nanjing Port disclosed that its stock trading has shown signs of market sentiment overheating, indicating potential irrational trading behavior [24] - Zhongnan Media signed a government procurement contract worth 1.009 billion yuan, ensuring stable revenue for its main business [25]
晚间公告丨5月22日这些公告有看头
Di Yi Cai Jing· 2025-05-22 10:28
Group 1 - Yong'an Pharmaceutical announced that its stock price has seen a significant short-term increase, indicating a risk of market sentiment overheating, although there are no major changes in the company's fundamentals [3] - China Power Construction reported that from January to April 2025, the company signed new contracts worth 386.49 billion yuan, a decrease of 4.9% year-on-year [4] - Wanhua Chemical announced a scheduled maintenance for its production facilities, including a technical upgrade for its ethylene unit, which is expected to last approximately five months, while ensuring that other units continue to operate normally [5] Group 2 - Changhong High-Tech received a warning letter from the Ningbo Securities Regulatory Bureau for failing to timely disclose related party transactions exceeding expected amounts, with the company secretary held responsible [6] - Gaweida plans to invest 10 million yuan in Blue Core Computing, acquiring a 0.6729% stake in the company, which focuses on RISC-V architecture chip solutions [7] Group 3 - Zhongnan Media signed a government procurement contract worth 1.009 billion yuan, ensuring stable revenue from educational materials for the 2025 fiscal year [9] - Hongli Zhihui's controlling shareholder plans to increase their stake in the company by investing between 25 million and 50 million yuan [11] - Xingye Co.'s controlling shareholder intends to reduce their stake by up to 1% of the total share capital due to personal asset allocation needs [12] - Chengdu Xian Dao's employee stockholding platform plans to invest between 25 million and 50 million yuan to increase its stake in the company, with no set price range for the purchase [13]
环氧丙烷概念下跌3.41%,主力资金净流出18股
Group 1 - The epoxy propylene sector experienced a decline of 3.41%, ranking among the top losers in the market, with notable declines in stocks such as Hongqiang Co., which hit the daily limit down, and others like Hongbaoli, Yida Co., and Bohai Chemical [1][2] - The sector saw a net outflow of 9.23 billion yuan in principal funds, with 18 stocks experiencing net outflows, and 6 stocks seeing outflows exceeding 30 million yuan. Hongbaoli led the outflow with 5.56 billion yuan, followed by Hangjin Technology, Wanhua Chemical, and Hongqiang Co. [2][3] - The top stocks with net inflows included Satellite Chemical, Zhongchumai, and Shida Shenghua, with inflows of 332.33 million yuan, 2.50 million yuan, and 1.99 million yuan respectively [2][3] Group 2 - The top losers in the epoxy propylene sector included Hongbaoli (-8.60%), Hangjin Technology (-3.77%), and Hongqiang Co. (-9.98%), with significant trading volumes and turnover rates [2][3] - The overall market sentiment reflected a bearish trend, with various sectors such as sodium-ion batteries and transgenic technology also experiencing declines, indicating a broader market pullback [2]
万华化学(600309) - 万华化学福建工业园停产检修公告
2025-05-22 08:30
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏, 并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据化工企业生产工艺的要求,为确保生产装置安全有效运行,按照年度计划, 本公司福建工业园 80 万吨/年 MDI 装置、36 万吨/年 TDI 装置、40 万吨/年 PVC 装置 及相关配套装置将于 2025 年 6 月 5 日开始停产检修,预计检修 45 天左右。 股票简称:万华化学 股票代码:600309 公告编号:临 2025-32 号 万华化学集团股份有限公司 福建工业园停产检修公告 本次停产检修是根据年度计划进行的例行检修,对公司的生产经营不会产生重大 影响。 特此公告。 万华化学集团股份有限公司 2025 年 5 月 23 日 ...
万华化学(600309) - 万华化学烟台产业园乙烯一期装置停产改造公告
2025-05-22 08:30
股票简称:万华化学 股票代码:600309 公告编号:临 2025-31 号 万华化学集团股份有限公司 万华化学集团股份有限公司 2025 年 5 月 23 日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏, 并对其内容的真实性、准确性和完整性承担个别及连带责任。 万华化学烟台产业园 100 万吨/年乙烯一期装置为实现原料多元化,将于 2025 年 6 月 3 日开始停产进行技术改造,改造周期约 5 个月。在此期间,烟台产业园 120 万吨/年乙烯二期装置正常生产,以尽量满足客户的需求。 此次停产改造后,乙烯一期装置原料由丙烷变为乙烷,通过资源配置形成新质生 产力,有效提升产业链竞争力。 特此公告。 烟台产业园乙烯一期装置停产技改公告 ...
万华化学:福建工业园80万吨/年MDI装置等停产检修
news flash· 2025-05-22 08:06
万华化学:福建工业园80万吨/年MDI装置等停产检修 智通财经5月22日电,万华化学(600309.SH)公告称,公司福建工业园80万吨/年MDI装置、36万吨/年TDI 装置、40万吨/年PVC装置及相关配套装置将于2025年6月5日开始停产检修,预计检修45天左右。本次 停产检修为年度例行检修,对公司生产经营不会产生重大影响。 ...
5.21犀牛财经晚报:金饰价格再次破千元 阿里大文娱更名“虎鲸文娱”
Xi Niu Cai Jing· 2025-05-21 10:27
Group 1: Gold Jewelry Prices - Domestic gold jewelry prices have surpassed 1000 yuan per gram again, influenced by the rise in international gold prices, with brands like Chow Tai Fook and Lao Miao increasing prices to 1008 yuan and 1004 yuan per gram respectively [1] Group 2: Real Estate Investment Trusts (REITs) - Huatai Suzhou Hengtai Rental Housing REIT was listed on the Shanghai Stock Exchange, with a total of 500 million fund shares sold at 2.73 yuan per share, raising a total of 1.367 billion yuan [1] Group 3: New Energy Vehicles - Global sales of new energy vehicles are projected to exceed 4 million units in Q1 2025, marking a 39% year-on-year increase, with new energy vehicles accounting for 18.4% of total global car sales in that quarter [1] Group 4: Robotics - The Lingxi X2 humanoid robot by Zhiyuan Robotics will begin its first round of pre-sales on May 22, with prices ranging from hundreds of thousands to several million yuan depending on hardware configuration [2] - Zhiyuan Robotics plans to release a quadruped robot product in Q2 2025, targeting family and other consumer scenarios [2] Group 5: AI Solutions - Red Hat has launched the Red Hat AI Inference Server, enhancing the deployment of generative AI in hybrid cloud environments, integrating Neural Magic technology for improved performance and cost efficiency [3] Group 6: Corporate Rebranding - Alibaba's entertainment division has been rebranded as "Whale Entertainment," with its film division set to be renamed "Damai Entertainment," aligning with the company's strategic focus [3] Group 7: Financing and Expansion - Shanghai Minxin Technology has completed nearly 100 million yuan in B+ round financing, aimed at expanding product lines, team growth, and establishing an overseas R&D center [4] Group 8: Automotive Industry - XPeng Motors reported Q1 2025 revenue of 15.81 billion yuan, a 141.5% increase year-on-year, with a projected revenue of 17.5 billion to 18.7 billion yuan for Q2 [4] - Jin Gu Co. has received a project notification from a global automotive leader to develop wheel products for American passenger vehicles, with production expected to start in 2026 [7] Group 9: Share Buyback - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan to optimize capital structure and enhance shareholder value [8] Group 10: Production Suspension - Lanhua Ketech's subsidiary, Yamei Danning, has suspended production due to the expiration of its business license and production capacity announcement, with the resumption date yet to be determined [9] Group 11: Strategic Partnerships - Jiemai Technology's subsidiary has signed a strategic cooperation agreement with a solid-state battery company to produce high-safety lightweight composite materials [11] Group 12: Market Performance - The market saw a mixed performance with the ChiNext Index rising by 0.83%, driven by gains in solid-state battery and innovative drug sectors, while other sectors faced declines [12]
5月21日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-21 10:14
Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]
上证中国制造主题指数上涨0.1%,前十大权重包含中国重工等
Jin Rong Jie· 2025-05-21 09:31
Core Points - The Shanghai Composite Index rose by 0.21%, while the Shanghai China Manufacturing Theme Index increased by 0.1%, closing at 1417.05 points with a trading volume of 40.378 billion yuan [1] - Over the past month, the Shanghai China Manufacturing Theme Index has increased by 2.74%, but it has decreased by 6.30% over the last three months and is down 3.76% year-to-date [1] - The index includes representative listed companies in sectors such as new generation information technology, high-end CNC machine tools and robotics, aerospace equipment, energy-saving and new energy vehicles, electric power equipment, new materials, biomedicine, and high-performance medical devices [1] Index Composition - The top ten weighted stocks in the Shanghai China Manufacturing Theme Index are: Wanhua Chemical (4.13%), Guodian NARI (3.56%), Longi Green Energy (3.54%), CRRC (3.43%), China Shipbuilding (2.72%), Kingsoft Office (2.55%), Tebian Electric (2.32%), United Imaging (2.2%), AVIC Shenyang Aircraft (2.03%), and China Shipbuilding Industry Corporation (1.95%) [1] - The index is fully composed of stocks listed on the Shanghai Stock Exchange, with a 100% representation [1] Industry Breakdown - The industry composition of the index shows that industrials account for 55.63%, information technology for 16.96%, materials for 14.03%, healthcare for 11.77%, and consumer discretionary for 1.62% [2] - The index samples are adjusted semi-annually, with adjustments occurring on the next trading day after the second Friday of June and December each year [2] - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]